RELB and neoplasm: IHC: PD-L1/RelB co-expression in PCa (CST anti-human PD-L1 Ab)WB: PD-L1 validation (Abcam anti-human/anti-mouse Ab)FCM: Tumor/T-cell PD-L1 analysis (APC/PE-conjugated PD-L1 Ab)